Mitochondrial structural and functional dynamics in Huntington's disease

P (Hemachandra) Reddy, Peizhong Mao, Maria Manczak

    Research output: Contribution to journalArticle

    102 Citations (Scopus)

    Abstract

    Huntington's disease (HD) is an autosomal, dominantly inherited neurodegenerative disorder, characterized by chorea, involuntary movements, and cognitive impairments. Tremendous progress has been made since the discovery of HD gene in 1993, in terms of developing animal models to study the disease process, unraveling the expression and function of wild-type and mutant huntingtin (Htt) proteins in the central and peripheral nervous systems, and understanding expanded CAG repeat containing mutant Htt protein interactions with CNS proteins in the disease process. HD progression has been found to involve several pathomechanisms, including expanded CAG repeat protein interaction with other CNS proteins, transcriptional dysregulation, calcium dyshomeostasis, abnormal vesicle trafficking, and defective mitochondrial bioenergetics. Recent studies have found that mutant Htt is associated with mitochondria and causes mitochondrial structural changes, decreases mitochondrial trafficking, and impairs mitochondrial dynamics in the neurons affected by HD. This article discusses recent developments in HD research, with a particular focus on intracellular and intramitochondrial calcium influx, mitochondrial DNA defects, and mitochondrial structural and functional abnormalities in HD development and progression. Further, this article outlines the current status of mitochondrial therapeutics with a special reference to Dimebon.

    Original languageEnglish (US)
    Pages (from-to)33-48
    Number of pages16
    JournalBrain Research Reviews
    Volume61
    Issue number1
    DOIs
    StatePublished - Jun 2009

    Fingerprint

    Huntington Disease
    Mutant Proteins
    Disease Progression
    Mitochondrial Dynamics
    Calcium
    Chorea
    Proteins
    Dyskinesias
    Peripheral Nervous System
    Mitochondrial DNA
    Neurodegenerative Diseases
    Energy Metabolism
    Mitochondria
    Central Nervous System
    Animal Models
    Neurons
    Research
    Genes

    Keywords

    • Calcium dyshomeostasis
    • Dimebon
    • Huntington's Disease
    • Mitochondria
    • Mitochondrial dynamics
    • Polyglutamine repeat

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Clinical Neurology

    Cite this

    Mitochondrial structural and functional dynamics in Huntington's disease. / Reddy, P (Hemachandra); Mao, Peizhong; Manczak, Maria.

    In: Brain Research Reviews, Vol. 61, No. 1, 06.2009, p. 33-48.

    Research output: Contribution to journalArticle

    Reddy, P (Hemachandra) ; Mao, Peizhong ; Manczak, Maria. / Mitochondrial structural and functional dynamics in Huntington's disease. In: Brain Research Reviews. 2009 ; Vol. 61, No. 1. pp. 33-48.
    @article{e662268b598b4db49fe69d195467b809,
    title = "Mitochondrial structural and functional dynamics in Huntington's disease",
    abstract = "Huntington's disease (HD) is an autosomal, dominantly inherited neurodegenerative disorder, characterized by chorea, involuntary movements, and cognitive impairments. Tremendous progress has been made since the discovery of HD gene in 1993, in terms of developing animal models to study the disease process, unraveling the expression and function of wild-type and mutant huntingtin (Htt) proteins in the central and peripheral nervous systems, and understanding expanded CAG repeat containing mutant Htt protein interactions with CNS proteins in the disease process. HD progression has been found to involve several pathomechanisms, including expanded CAG repeat protein interaction with other CNS proteins, transcriptional dysregulation, calcium dyshomeostasis, abnormal vesicle trafficking, and defective mitochondrial bioenergetics. Recent studies have found that mutant Htt is associated with mitochondria and causes mitochondrial structural changes, decreases mitochondrial trafficking, and impairs mitochondrial dynamics in the neurons affected by HD. This article discusses recent developments in HD research, with a particular focus on intracellular and intramitochondrial calcium influx, mitochondrial DNA defects, and mitochondrial structural and functional abnormalities in HD development and progression. Further, this article outlines the current status of mitochondrial therapeutics with a special reference to Dimebon.",
    keywords = "Calcium dyshomeostasis, Dimebon, Huntington's Disease, Mitochondria, Mitochondrial dynamics, Polyglutamine repeat",
    author = "Reddy, {P (Hemachandra)} and Peizhong Mao and Maria Manczak",
    year = "2009",
    month = "6",
    doi = "10.1016/j.brainresrev.2009.04.001",
    language = "English (US)",
    volume = "61",
    pages = "33--48",
    journal = "Brain Research Reviews",
    issn = "0165-0173",
    publisher = "Elsevier",
    number = "1",

    }

    TY - JOUR

    T1 - Mitochondrial structural and functional dynamics in Huntington's disease

    AU - Reddy, P (Hemachandra)

    AU - Mao, Peizhong

    AU - Manczak, Maria

    PY - 2009/6

    Y1 - 2009/6

    N2 - Huntington's disease (HD) is an autosomal, dominantly inherited neurodegenerative disorder, characterized by chorea, involuntary movements, and cognitive impairments. Tremendous progress has been made since the discovery of HD gene in 1993, in terms of developing animal models to study the disease process, unraveling the expression and function of wild-type and mutant huntingtin (Htt) proteins in the central and peripheral nervous systems, and understanding expanded CAG repeat containing mutant Htt protein interactions with CNS proteins in the disease process. HD progression has been found to involve several pathomechanisms, including expanded CAG repeat protein interaction with other CNS proteins, transcriptional dysregulation, calcium dyshomeostasis, abnormal vesicle trafficking, and defective mitochondrial bioenergetics. Recent studies have found that mutant Htt is associated with mitochondria and causes mitochondrial structural changes, decreases mitochondrial trafficking, and impairs mitochondrial dynamics in the neurons affected by HD. This article discusses recent developments in HD research, with a particular focus on intracellular and intramitochondrial calcium influx, mitochondrial DNA defects, and mitochondrial structural and functional abnormalities in HD development and progression. Further, this article outlines the current status of mitochondrial therapeutics with a special reference to Dimebon.

    AB - Huntington's disease (HD) is an autosomal, dominantly inherited neurodegenerative disorder, characterized by chorea, involuntary movements, and cognitive impairments. Tremendous progress has been made since the discovery of HD gene in 1993, in terms of developing animal models to study the disease process, unraveling the expression and function of wild-type and mutant huntingtin (Htt) proteins in the central and peripheral nervous systems, and understanding expanded CAG repeat containing mutant Htt protein interactions with CNS proteins in the disease process. HD progression has been found to involve several pathomechanisms, including expanded CAG repeat protein interaction with other CNS proteins, transcriptional dysregulation, calcium dyshomeostasis, abnormal vesicle trafficking, and defective mitochondrial bioenergetics. Recent studies have found that mutant Htt is associated with mitochondria and causes mitochondrial structural changes, decreases mitochondrial trafficking, and impairs mitochondrial dynamics in the neurons affected by HD. This article discusses recent developments in HD research, with a particular focus on intracellular and intramitochondrial calcium influx, mitochondrial DNA defects, and mitochondrial structural and functional abnormalities in HD development and progression. Further, this article outlines the current status of mitochondrial therapeutics with a special reference to Dimebon.

    KW - Calcium dyshomeostasis

    KW - Dimebon

    KW - Huntington's Disease

    KW - Mitochondria

    KW - Mitochondrial dynamics

    KW - Polyglutamine repeat

    UR - http://www.scopus.com/inward/record.url?scp=67349247037&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=67349247037&partnerID=8YFLogxK

    U2 - 10.1016/j.brainresrev.2009.04.001

    DO - 10.1016/j.brainresrev.2009.04.001

    M3 - Article

    VL - 61

    SP - 33

    EP - 48

    JO - Brain Research Reviews

    JF - Brain Research Reviews

    SN - 0165-0173

    IS - 1

    ER -